
Rojelio Mejia MD
Assistant Professor, Medicine, Baylor Coll of Med
Join to view full profile
1709 Dryden Rd# 620Houston, TX 77030
Phone+1 713-798-9121
Dr. Mejia is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2008 - 2012
University of Virginia Medical CenterResidency, Internal Medicine, 2006 - 2008
Michigan State University College of Human MedicineClass of 2006
Certifications & Licensure
TX State Medical License 2012 - 2027
VA State Medical License 2006 - 2012
Publications & Presentations
PubMed
- Bacterial fecal microbiome composition associated with HIV stage among rural and peri-urban adults living with HIV in Uganda.Bożena M Morawski, Elise R Morton, Miya Yunus, Claudia Muñoz-Zanzi, Rojelio Mejia
BMC Infectious Diseases. 2026-03-10 - Impact of Anthelmintic Therapy for Invasive Helminth Infection on Microbial Translocation, Inflammation, and Immune Response among Ugandans Living with HIV: A Randomiz...Bożena M Morawski, Miya Yunus, Stefanie Sowinski, Grace Turyasingura, Anna Gabrielle Bottazzi
The American Journal of Tropical Medicine and Hygiene. 2025-12-03 - Impact of Intestinal Parasitic Infections on Gut Epithelial Barrier and Inflammation among Foreign-Born Persons Living with HIV.Melissa Reimer-McAtee, Jose Serpa, Casey L McAtee, Emma Ortega, Anoma Somasunderam
The American Journal of Tropical Medicine and Hygiene. 2025-12-03
Press Mentions
Infrastructure Neglect and Poverty Lead to Parasites in the Mississippi DeltaJanuary 1st, 2025
‘People Should Be Aware’: Eggs of Tiny Infectious Worm Found in Parks in New York and EuropeJune 30th, 2022
Billionaire Mark Cuban’s New Drug Company Is Producing Low-Cost Generic Drugs Cutting 90% of the MarkupJanuary 29th, 2021
Grant Support
- Evaluation of a novel Tc-24 ELISA test in post-treatment efficacy for Chagas disease.BAYLOR COLLEGE OF MEDICINE2025–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









